Riskpilot← Back to searchSign inGet full accessJohnson & Johnson Aktiebolag
ABActiveOrg 5560632514Kolonnvägen 45Wholesale of pharmaceutical and medical goods · NACE 4646Est. 1956157 employees
Revenue 2024
SEK 1,4B
+5% vs 2023
EBITDA margin
5.2%
-14% vs 2023
Equity ratio
60.2%
Financial strength
Net profit 2024
SEK 299,8M
+298% vs 2023
| Revenue | SEK 1,4B | +5% |
| EBITDA | SEK 72M | -14% |
| Net profit | SEK 299,8M | +298% |
| Total assets | SEK 701,9M | +17% |
| Equity | SEK 422,5M | +10% |
| Employees | 157 | — |
Legal name
Johnson & Johnson Aktiebolag
Org number
5560632514
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
2 juli 1956
Share capital
SEK 5 500 000
Employees
157 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall bedriva verksamhet avseende tillverkning av och handel med företrädesvis sjukvårds- och hälsovårdsartiklar, apoteksvaror, läkemedel, textil, plast-, tape-, cellulosa-, pappers- och gummivaror samt kosmetiska artiklar samt därmed förenlig verksamhet.
Address
Kolonnvägen 45
Phone
+4686262200
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 991 289 | 1 053 385 | 1 195 581 | 1 326 215 | 1 396 591 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 53 079 | 32 219 | 43 878 | 83 586 | 71 985 |
| Depreciation & amort. | — | — | −7 820 | −5 026 | −5 408 |
| EBIT | 53 079 | 32 219 | 36 058 | 78 560 | 66 577 |
| Net financials | 2 | 14 | 644 | 4 907 | 242 477 |
| Profit before tax | 53 048 | 32 201 | 36 916 | 95 854 | 318 323 |
| Tax | −12 939 | −8 108 | −8 568 | −20 478 | −18 492 |
| Net profit | 40 109 | 24 093 | 28 348 | 75 376 | 299 831 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 441 214 | 515 252 | 525 968 | 600 373 | 701 920 |
| Equity | 262 131 | 288 961 | 307 645 | 382 650 | 422 546 |
| Long-term debt | 0 | 0 | 0 | 1 028 | 765 |
| Short-term debt | 179 083 | 226 291 | 218 323 | 216 695 | 278 609 |
| Total debt | 179 083 | 226 291 | 218 323 | 217 723 | 279 374 |
EBITDA margin
5.2%
This company
15.8%
Market median
-67% vs market
20202024
Equity ratio
60.2%
This company
38.2%
Market median
+58% vs market
20202024
Return on equity
71.0%
This company
18.4%
Market median
+286% vs market
20202024
Net profit margin
21.5%
This company
8.1%
Market median
+165% vs market
20202024
Asset turnover
1.99×
This company
1.12×
Market median
+78% vs market
20202024
Debt / equity
0.66×
This company
0.62×
Market median
+6% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AK Chief Auditor | Chief Auditor | 2021 |
| Former (2) | ||
JE Chief Auditor | Chief Auditor | 2020 – 2021 |
DW External Signatory | External Signatory | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2022 | |
| Board of Directors | 2024 | |
| Board of Directors | 2020 | |
| Former (7) | ||
| Chairman | 2021 – 2022 | |
| Chairman | 2020 – 2021 | |
| Board of Directors | 2022 – 2023 | |
| Chairman | 2020 – 2020 | |
| Board of Directors | 2024 – 2024 | |
| Chairman | 2022 – 2022 | |
| Board of Directors | 2020 – 2020 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
JOHNSON & JOHNSON CORPJohnson & Johnson Nordic AB
Johnson & Johnson Aktiebolag (this company)Uab Johnson & JohnsonUAB JOHNSON & JOHNSONBoard members of Johnson & Johnson Aktiebolag also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jeanette Elisabeth Cranning | Chief Auditor | 0 companies |
| Anna Kristina Wergelius | Chief Auditor | 0 companies |
| Douglas William Thorburn | External Signatory | 0 companies |
| Mehmet Refik Öner | Chairman | 0 companies |
| Liana Akhmetzhanova | Board of Directors | 0 companies |
| Filip Arthur F Standaert | Chairman | 0 companies |
| Filip Arthur f. Standaert | Chairman | 0 companies |
| Åsa Christina Ardesjö | Board of Directors | 0 companies |
| Jonas Dinnesen | Board of Directors | 0 companies |
| Frederik Richard van Batenburg | Chairman | 0 companies |
| Anna Maria Ulrika Back | Board of Directors | 0 companies |
| Mehmet Refik Öner | Chairman | 0 companies |
| Hanna Karen Obersteller | Board of Directors | 0 companies |